President Joe Biden signed orders on Monday to push more government dollars to the U.S. biotechnology industry, as he promoted his initiative to create new treatments and cut the death rate from cancer.
https://www.pharmalive.com/wp-content/uploads/2022/09/ReutersBiden9-13-2022.jpg8001200Reuters Healthhttps://www.pharmalive.com/wp-content/uploads/2020/01/Pharmalive_4c-300x37.pngReuters Health2022-09-13 10:13:062022-09-13 10:57:53Biden touts ‘Cancer Moonshot’ on JFK speech anniversary in Boston
